Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients.

Clinical trial NCT04229264 · UNKNOWN

Trial details

NCT number: NCT04229264
Sponsor: Science Valley Research Institute
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Critical Limb Ischemia

Start date: 2020-01-09
Primary completion: 2022-02-02
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.